Trials / Unknown
UnknownNCT04503356
OMNI in Open-angle Glaucoma Treatment
Evaluation of the Effectiveness of the New Surgical Method OMNI in the Treatment of Adult Patients With Open-angle Glaucoma
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 17 (actual)
- Sponsor
- Centre of Postgraduate Medical Education · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This single-center, prospective study will assess safety and effectiveness of 360 degree viscodilation followed by up to 360 degree trabeculotomy used in patients with early or moderate open-angle glaucoma in a real-world setting either as a standalone procedure in pseudophakic patients (or phakic) or combined with phacoemulsification cataract procedures. Medication usage, IOP and secondary surgical procedures necessary for IOP control will be analyzed during the follow-up period.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | OMNI as a standalone procedure | It uses a single, self-sealing clear corneal incision with ab-interno transluminal 360 degree viscodilation of Schlemm's canal followed by up to 360 degree trabeculotomy performed using the OMNI Surgical System as a standalone procedure. |
| PROCEDURE | OMNI combined with cataract surgery | Phacoemulsification with intraocular lens implantation is performed. Then, ab-interno transluminal 360 degree viscodilation of Schlemm's canal followed by up to 360 degree trabeculotomy performed using the OMNI Surgical System. |
Timeline
- Start date
- 2018-04-17
- Primary completion
- 2019-12-03
- Completion
- 2021-12-01
- First posted
- 2020-08-07
- Last updated
- 2020-08-11
Locations
1 site across 1 country: Poland
Source: ClinicalTrials.gov record NCT04503356. Inclusion in this directory is not an endorsement.